Thermo Fisher Scientific | TMO - Assets

Stock Price
468.04
Daily Change
-1.67 -0.36%
Monthly
-2.50%
Yearly
11.08%
Q2 Forecast
459.66

Thermo Fisher Scientific reported $113.28B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Agilent USD 12.81B 86M Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Bio Techne USD 2.52B 3.45M Dec/2025
Bio-Rad Laboratories USD 10.58B 880.1M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Bruker USD 6.24B 193.5M Dec/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Danaher USD 83.54B 80M Mar/2026
Dentsply International USD 5.43B 224M Dec/2025
Edwards Lifesciences USD 13.7B 425M Dec/2025
General Electric Aerospace USD 128.45B 1.72B Mar/2026
Henry Schein USD 11.22B 118M Dec/2025
Illumina USD 6.64B 467M Dec/2025
Intuitive Surgical USD 20.11B 347.7M Mar/2026
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Laboratory Of America USD 18.39B 131.1M Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Mettler Toledo International USD 3.71B 191.18M Dec/2025
Myriad Genetics USD 706.6M 21.5M Dec/2025
Olympus JPY 1.46T 73.12B Dec/2025
OraSure Technologies USD 403.17M 19.93M Dec/2025
Quest Diagnostics USD 16.67B 448M Mar/2026
Repligen USD 2.95B 25.99M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Veracyte USD 1.41B 38.23M Dec/2025
Waters USD 5.08B 221.41M Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025